Cargando…
Drug Repurposing for Cancers With Limited Survival: Protocol for a Retrospective Cohort Study
BACKGROUND: Only 5% of the molecules tested in oncology phase 1 trials reach the market after an average of 7.5 years of waiting and at a cost of tens of millions of dollars. To reduce the cost and shorten the time of discovery of new treatments, “drug repurposing” (research with molecules already a...
Autores principales: | Rodríguez-Molinero, Alejandro, Pérez-López, Carlos, Salazar González, Jose L, Garcia-Lerma, Esther, Álvarez-García, Juan A, Soria Morillo, Luis M, Salas Fernández, Tomás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686206/ https://www.ncbi.nlm.nih.gov/pubmed/37962929 http://dx.doi.org/10.2196/48925 |
Ejemplares similares
-
Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review
por: Sweiti, Hussein, et al.
Publicado: (2015) -
Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
por: Geisler, Benjamin P., et al.
Publicado: (2021) -
Single-Board-Computer Clusters for Cloudlet Computing in Internet of Things
por: Fernández-Cerero, Damián, et al.
Publicado: (2019) -
In silico approaches for drug repurposing in oncology: Protocol for a scoping review of existing evidence
por: Cavalcante, Bruno Raphael Ribeiro, et al.
Publicado: (2022) -
Virtual screening on the web for drug repurposing: a primer
por: Chen, Yu Wai, et al.
Publicado: (2021)